AbbVie Expands Its Board
An SEC filing says AbbVie expanded its board on October 14, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AbbVie shares edge higher after positive Phase 3 topline results
AbbVie stock rose in early trading after the company reported positive Phase 3 topline results for its menstrual migraine treatment atogepant (QULIPTA/AQUIPTA) in the LUNA trial. AbbVie also declared a quarterly cash dividend of $1.73 per share.